Who is the first?

Head of Rospatent Grigory Ivliev tells about the development of drugs for COVID-19, the cost of patents and protection of rights

According to the Head of Rospatent Grigory Ivliev in an interview with “Rossiyskaya Gazeta”, in April and May 2020, the Office received more than 90 applications related to the treatment of coronavirus. To consider this topic, they established a priority order and attracted the most powerful experts. As a result, instead of 5-6 months, applications are considered for 2 months. One patent for a vaccine, one for diagnostic test systems and one for a device for disinfecting indoor air has already been issued; other applications for inventions of therapeutic and prophylactic agents for combating coronavirus and disinfectants are also under consideration. The inventor can obtain patent protection in several states at once through the PCT system. The international fee for filing such an application today is $ 1,337 with individuals paying only 10% of this amount. About 1.3 thousand Russian inventors turn to the PCT system for the year. Those who need protection in several countries can also turn to the European and Eurasian forms of patenting. The Eurasian Patent Office is the only one where Russian inventors can apply directly and bypassing Rospatent. Rospatent also prepared all the necessary regulatory framework for the protection of geographical indications. Such protection will greatly expand the positioning capabilities of regional brands.






Author: Alexey Duel




Last page update:

All updates
next news
Working Group on the WIPO Madrid System: the 19th Session Concluded
go to news list

Font size